Stephen Sullivan, PhD, MBA, programme Manager/International Liaison Officer at the The Global Alliance for iPSC Therapies (GAiT) stresses the importance of establishing common standards for clinical-grade iPS, in order to accelerate translation to patients and reduce the cost iPS-based cell therapy products.